Exagen Inc.
NASDAQ:XGN
2.79 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 52.548 | 45.563 | 48.299 | 41.975 | 40.387 | 32.44 | 26.807 | 17.946 | 11.663 | 3.055 | 0.926 |
| Cost of Revenue
| 23.092 | 24.214 | 20.588 | 16.559 | 18.808 | 15.379 | 14.137 | 9.533 | 6.885 | 2.83 | 1.974 |
| Gross Profit
| 29.456 | 21.349 | 27.711 | 25.416 | 21.579 | 17.061 | 12.67 | 8.413 | 4.778 | 0.225 | -1.048 |
| Gross Profit Ratio
| 0.561 | 0.469 | 0.574 | 0.606 | 0.534 | 0.526 | 0.473 | 0.469 | 0.41 | 0.074 | -1.132 |
| Reseach & Development Expenses
| 4.865 | 9.876 | 7.237 | 3.568 | 2.176 | 2.125 | 1.551 | 1.367 | 1.287 | 0.897 | 1.055 |
| General & Administrative Expenses
| 45.928 | 49.018 | 42.841 | 35.733 | 27.102 | 18.275 | 17.52 | 15.906 | 13.966 | 6.564 | 4.855 |
| Selling & Marketing Expenses
| 1.5 | 3 | 1.7 | 1.3 | 1.6 | 1.4 | 1.3 | 1.5 | 1.1 | 0.429 | 0.294 |
| SG&A
| 47.428 | 52.018 | 44.541 | 37.033 | 28.702 | 19.675 | 18.82 | 17.406 | 15.066 | 6.993 | 5.149 |
| Other Expenses
| 0 | 5.506 | 0.016 | 0.984 | 0.51 | 0.141 | 0.186 | 1.217 | -0.497 | -0.083 | 0.007 |
| Operating Expenses
| 52.293 | 61.894 | 51.778 | 40.601 | 30.878 | 21.941 | 20.557 | 19.065 | 16.573 | 8.104 | 6.418 |
| Operating Income
| -22.837 | -40.545 | -24.067 | -15.185 | -9.299 | -4.88 | -7.836 | -10.388 | -11.556 | -9.144 | -6.826 |
| Operating Income Ratio
| -0.435 | -0.89 | -0.498 | -0.362 | -0.23 | -0.15 | -0.292 | -0.579 | -0.991 | -2.993 | -7.371 |
| Total Other Income Expenses Net
| -0.819 | -1.618 | -2.609 | -1.581 | -2.714 | -3.074 | -18.344 | -8.542 | -3.438 | -4.31 | 0.184 |
| Income Before Tax
| -23.656 | -47.669 | -26.676 | -16.766 | -12.013 | -7.954 | -26.18 | -18.93 | -14.994 | -13.454 | -7.282 |
| Income Before Tax Ratio
| -0.45 | -1.046 | -0.552 | -0.399 | -0.297 | -0.245 | -0.977 | -1.055 | -1.286 | -4.404 | -7.864 |
| Income Tax Expense
| 0.033 | -0.282 | 0.175 | -0.079 | 0.025 | 0.058 | -0.549 | 0.253 | -0.013 | 0.042 | 0.042 |
| Net Income
| -23.689 | -47.387 | -26.851 | -16.687 | -12.038 | -8.012 | -25.631 | -19.183 | -14.981 | -13.496 | -7.324 |
| Net Income Ratio
| -0.451 | -1.04 | -0.556 | -0.398 | -0.298 | -0.247 | -0.956 | -1.069 | -1.284 | -4.418 | -7.909 |
| EPS
| -1.34 | -2.77 | -1.68 | -1.32 | -0.96 | -127.16 | -406.81 | -305.48 | -265.79 | -251.43 | -206.86 |
| EPS Diluted
| -1.34 | -2.77 | -1.68 | -1.32 | -0.96 | -127.16 | -406.81 | -305.48 | -265.79 | -251.43 | -206.86 |
| EBITDA
| -19.153 | -43.113 | -23.103 | -13.655 | -7.931 | -4.355 | -22.562 | -13.55 | -11.495 | -12.058 | -6.422 |
| EBITDA Ratio
| -0.393 | -0.872 | -0.498 | -0.338 | -0.218 | -0.124 | -0.268 | -0.477 | -1.006 | -2.457 | -7.625 |